Table II.
Factors | Stent group (n=49) | Catheter group (n=40) | χ2 test | P-value |
---|---|---|---|---|
Open surgery rate | 2 (4.08) | 3 (7.50) | 0.485 | 0.486 |
Incision infection | 3 (6.12) | 2 (5.00) | ||
Anastomotic fistula | 1 (2.04) | 2 (5.00) | ||
Lower extremity venous thrombosis | 1 (2.04) | 0 (0.00) | ||
Abdominal infection | 2 (4.08) | 2 (5.00) | ||
Abdominal pain | 4 (8.16) | 3 (7.50) | ||
Fever | 3 (6.12) | 4 (10.00) | ||
Incidence of adverse reactions (%) | 28.57 | 32.50 | 0.161 | 0.688 |
Hepatic metastases | 1 (2.04) | 0 (0.00) | ||
Pulmonary metastasis | 0 (0.00) | 1 (2.56) | ||
Brain metastases | 0 (0.00) | 1 (2.56) | ||
Gastric metastasis | 1 (2.04) | 0 (0.00) | ||
Local recurrence rate (%) | 4.26 | 5.13 | 0.037 | 0.848 |